

Cardiovascular disease (CVD), a composite of coronary heart disease (CHD), cerebrovascular disease, and heart failure, remains the leading cause of morbidity and mortality worldwide. Although mortality due to CHD has shown major decreases in high-income regions,1 these declines have not been noted in the case of heart failure. Diabetes represents a major risk factor for the development of heart failure, and is also associated with increased risk of progression from asymptomatic to symptomatic heart failure.
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet